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Abstract (160 words) 1 
We examined whether slower pulmonary O2 uptake (Vࡆ O2p) kinetics in hypoxia is a consequence 2 
of: a) hypoxia alone (lowered arterial O2 pressure), b) hyperventilation-induced hypocapnia 3 
(lowered arterial CO2 pressure), or c) a combination of both. Eleven participants performed 3-5 4 
repetitions of step-changes in cycle ergometer power output from 20W to 80% lactate threshold 5 
in the following conditions: i) normoxia (CON; room air); ii) hypoxia (HX, inspired O2 =12%; 6 
lowered end-tidal O2 pressure [PETO2] and end-tidal CO2 pressure [PETCO2]); iii) hyperventilation 7 
(HV; increased PETO2 and lowered PETCO2); and iv) normocapnic hypoxia (NC-HX; lowered 8 
PETO2 and PETCO2 matched to CON). Ventilation was increased (relative to CON) and matched 9 
between HX, HV, and NC-HX conditions. During each condition Vࡆ O2p was measured and phase 10 
II Vࡆ O2p kinetics were modeled with a mono-exponential function. The Vࡆ O2p time constant was 11 
different (p<0.05) amongst all conditions: CON, 26±11s; HV, 36±14s; HX, 46±14s; and NC-12 
HX, 52±13s. Hypocapnia may prevent further slowing of Vࡆ O2p kinetics in hypoxic exercise. 13 
 14 
Key words: O2 uptake kinetics, near-infrared spectroscopy, hypocapnia, CO2, exercise, end-tidal 15 
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1. Introduction 16 
Breathing a gas mixture containing a fractional oxygen (O2) concentration lower than that 17 
of air (i.e., hypoxia) reduces the partial pressure of inspired O2 (PiO2) and O2 concentration of the 18 
arterial blood (CaO2). Without an adequate compensatory response, hypoxia may limit O2 supply 19 
to the peripheral tissues. When a step-increase in moderate-intensity exercise power output is 20 
performed in conditions of acute hypoxia (12-15% inspired fraction of O2), the rate of 21 
adjustment of pulmonary O2 uptake (Vࡆ O2p) (i.e., as described by the phase II time constant 22 
[ĲVࡆ O2p]) is slowed relative to the same step-transition performed in normoxic conditions (Bowen 23 
et al., 2013; Engelen et al., 1996; Hughson and Kowalchuk, 1995; MacDonald et al., 2000; 24 
Perrey et al., 2005; Spencer et al., 2012a) suggesting that convective and/or diffusive O2 delivery 25 
to the active muscles may limit muscle O2 utilization (Vࡆ O2m), necessitating a greater contribution 26 
of substrate level phosphorylation to the exercise energetics. Hypoxia, CO2 retention, slow Vࡆ O2p 27 
kinetics, and low exercise tolerance are characteristics common to several highly prevalent heart 28 
and respiratory pathologies such as heart failure (Bowen et al., 2012) and restrictive or 29 
obstructive lung disease (Nery et al., 1982). The hypoxia and CO2 retention that frequently 30 
accompanies these conditions limits the adjustment of Vࡆ O2p on transition to exercise, but the 31 
mechanisms by which these contribute to slow Vࡆ O2p kinetics remains incomplete. 32 
Relative to normoxia, hypoxic exercise induces a greater rate of ventilation (Vࡆ E) (Adams 33 
and Welch, 1980; Engelen et al., 1996; MacDonald et al., 2000) due to reflex-activation of low 34 
PaO2-sensitive peripheral chemoreceptors (Buckler and Vaughan-jones, 1994; Cunningham et 35 
al., 1986; Duffin, 1990). A consequence of an increased ventilatory drive (relative to metabolic 36 
demand) is a reduction in the partial pressure of arterial CO2 (PaCO2) (Chin et al., 2007), which 37 
causes a shift in the carbonic anhydrase-catalyzed equilibrium reaction between CO2 and 38 
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bicarbonate (HCO3-) with an increase in flux in the direction of CO2 formation (law of mass 39 
action). The subsequent reduction in arterial [HCO3-] and hydrogen ions ([H+]) results in a state 40 
of respiratory alkalosis. For example, Parolin et al., (2000) reported a near two-fold greater Vࡆ E 41 
concomitant with a 15 mmHg (~35%) reduction in end-tidal CO2 pressure (PETCO2, a reasonable 42 
surrogate for PaCO2 in a healthy lung (Jones et al., 1979)) during steady-state submaximal 43 
exercise in hypoxia (FIO2 = 0.12). Additionally, considerable reductions in arterial [H+] (Adams 44 
and Welch, 1980; Parolin et al., 2000) and muscle [H+] (Green et al., 1992) have been observed 45 
during submaximal exercise in hypoxic relative to normoxic conditions. Thus, hyperventilation-46 
induced hypocapnic alkalosis is a physiological consequence of exercise in hypoxia. 47 
When a hyperventilation manoeuvre (decreasing PETCO2 and increasing PETO2) is 48 
performed during exercise whilst breathing room air, Vࡆ O2p kinetics are slowed (Chin et al., 2013, 49 
2010a, 2010b, 2007; Hayashi et al., 1999; Ward et al., 1983) by a magnitude similar to that 50 
reported during hypoxic exercise (i.e., twofold increase in ĲVࡆ O2p). Furthermore, the proposed 51 
mechanisms by which hyperventilation or hypoxia slow the on-transient Vࡆ O2p response are also 52 
very similar. For example, effects have been attributed to reductions in convective and diffusive 53 
O2 delivery in both conditions of acute hypoxia (DeLorey et al., 2004; Koskolou et al., 1997; 54 
MacDonald et al., 2000) and hyperventilation-induced hypocapnic alkalosis (Chin et al., 2013, 55 
2010a, 2010b; Hayashi et al., 1999). Furthermore, similar increases in the rates of glycogenolysis 56 
and glycolysis, and decreases in the rates of pyruvate oxidation, also have been reported (relative 57 
to a control) during submaximal exercise performed in either conditions (LeBlanc et al., 2002; 58 
Linnarsson et al., 1974; Parolin et al., 2000), implicating a delayed activation of rate-limiting 59 
enzymes (e.g., pyruvate dehydrogenase) as a reason for the observed slower Vࡆ O2p kinetics. 60 
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Therefore, the slowing of Vࡆ O2p kinetics in hyperventilation or hypoxia (relative to normal 61 
conditions) may stem from similar hypocapnia-specific mechanisms.  62 
 It is unclear whether the slower Vࡆ O2p kinetics observed during hypoxia is a consequence 63 
of: a) lower arterial O2 availability, b) lower arterial CO2, or c) a combination of both. Recently, 64 
Chin et al., (2013) demonstrated that hyperventilation in normoxia performed with CO2 added to 65 
the inspirate prevented the hypocapnia and induced-alkalosis and restored the slower Vࡆ O2p 66 
kinetics back towards control values. Therefore, here we examined the role of hyperventilation 67 
and hypocapnia in the hypoxia-induced slowing of Vࡆ O2p kinetics. It was hypothesized that the 68 
slower Vࡆ O2p kinetics in hypoxia compared to a normoxic control was related to effects of 69 
hypocapnia in addition to reduced O2 delivery, and that addition of inspired CO2 during hypoxic 70 
exercise (i.e., normocapnic hypoxia) would return (i.e., speed) Vࡆ O2p kinetics back towards 71 
control (normocapnic normoxia) values. 72 
 73 
2. Materials and Methods 74 
2.1 Participants 75 
Eleven healthy young adult men (age, 24 ± 4 yrs (mean ± SD); body mass, 81 ± 8 kg; height, 182 76 
± 5 cm; peak Vࡆ O2, 44.2 ± 6.1 mL·kg-1·min-1) volunteered and gave written informed consent to 77 
participate in the study. All procedures were approved by The University of Western Ontario 78 
Ethics Committee for Research on Human Subjects. All subjects were non-smokers who were 79 
free of any musculoskeletal, respiratory, cardiovascular, and metabolic conditions and who were 80 
not taking any medications that might influence cardiorespiratory or metabolic responses to 81 
exercise.      82 
2.2 Pre-experimental Protocol 83 
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On the first visit, each subject reported to the laboratory to perform a ramp incremental exercise 84 
test to volitional exhaustion (20 W baseline for 4 min followed by a 25 W·min-1 ramp) on an 85 
electronically-braked cycle ergometer (model: Velotron, RacerMate Inc., Seattle, WA, USA) for 86 
determination of peak Vࡆ O2p (Vࡆ O2peak), peak power output (POpeak) and to estimate the lactate 87 
threshold ( Lș ). Participants were asked to maintain a cadence of ~60 rpm during the test. Vࡆ O2peak 88 
was defined as the greatest 20-s Vࡆ O2p computed from a rolling average and peak power output 89 
was defined as the power output achieved at termination of the ramp incremental test. Lș  was 90 
determined by visual inspection using standard ventilatory and gas exchange indices as 91 
previously described  (Beaver et al., 1986).  92 
 Before beginning the experiments, subjects were familiarized with the hyperventilation 93 
manoeuvre. Subjects were instructed to breathe in time with an audible que by metronome, while 94 
tidal volumes were continuously displayed on a monitor. Subjects were required to meet target 95 
volumes during each inspiration and expiration in time with the metronome. Tidal volumes and 96 
breathing frequencies were manipulated so as to lower and maintain PETCO2 at ~30 mmHg  a 97 
value previously reported during exercise using FiO2 = 0.12, as used here (Lador et al., 2013; 98 
Parolin et al., 2000).  99 
2.3 Experimental Conditions 100 
 The study used four experimental conditions: control (CON), hyperventilation (HV), hypoxia 101 
(HX), and normocapnic hypoxia (NC-HX). Each condition involved different requirements for 102 
ventilation and inspired gas mixtures (Table 1), with multiple repetitions performed in each 103 
condition (see Exercise Protocol). All conditions began with a resting period of 22 min, during 104 
which subjects breathed quietly for the first 2 min (pre-accommodation period), then either 105 
continued to breath normally (i.e., CON) or were instructed to hyperventilate (i.e., HV, HX, and 106 
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NC-HX) for the next 20 min (accommodation period) at a constant breathing frequency and tidal 107 
volume sufficient to reduce and maintain PETCO2 at ~30 mmHg. This target ventilation was used 108 
in all subsequent HV, HX, and NC-HX trials to ensure equivalence in breathing frequency and 109 
tidal volume and thus, total ventilation for these conditions.  110 
 For all conditions, subjects began at the pre-accommodation period by breathing room 111 
air. To blind subjects to the testing condition, in CON they breathed gas from a Douglas bag 112 
(filled with air: ~0.03% CO2, ~21% O2, balance N2). A three-way T-shaped stopcock and hose 113 
(Hans Rudolph, Kansas City, MO, USA) joined the Douglas bag to the breathing apparatus, 114 
which included a two-way Y-shaped non-rebreathing valve (Two-way NRB Y-valve 2730; Hans 115 
Rudolph, Kansas City, MO, USA), a pneumotach, volume turbine and mouthpiece (see Data 116 
Collection). At the start of the accommodation period, an assistant manually changed (i.e., HX 117 
and NC-HX trials only) or performed a dummy change (i.e., CON and HV trials only) of the 118 
direction of the respiratory flow path such that subjects switched from breathing room air to: a) 119 
breathing a hypoxic gas mixture from the Douglas bag (i.e., HX and NC-HX trials), or b) 120 
continuing to breathe room air (i.e., CON and HV trials). Additionally, during NC-HX trials, an 121 
assistant continuously monitored and maintained PETCO2 around CON values by introducing an 122 
inspirate containing ~ 5% CO2, 12% O2, and balance N2 from a pressurized tank via a small hose 123 
introduced distal to the inflow port on the two-way non-rebreathing valve.  124 
 Breath-by-breath respiratory variables were displayed (PowerLab Chart v.7.3.1; 125 
ADInstruments Inc., Colorado, CO, USA), allowing continuous feedback to the subject for 126 
maintenance of required tidal volumes. The PETCO2 and PETO2 were not visible to the subjects 127 
during any trial to avoid alerting the subject to the intervention being used. However, subjects 128 
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were not blinded to the CON condition where they breathed spontaneously, with no instruction 129 
given regarding rate and depth of breathing.  130 
2.4 Exercise Protocol 131 
 Subjects were seated on the cycle ergometer throughout the accommodation period.  After 20 132 
min subjects began cycling at 20 W for 6 min after which the power output was increased 133 
instantaneously to a power output equivalent to 80% Lș for an additional 6 min. During cycling 134 
all subjects were instructed to maintain a cadence of 60 rpm. The protocol was repeated 3-5 135 
times per condition (i.e., CON, HV, HX, NC-HX) to improve the signal-to-noise ratio and thus 136 
the confidence in the measured responses and kinetic parameter estimates. In order to match 137 
PETCO2 between CON and NC-HX, it was necessary to precede the first NC-HX trial by at least 138 
one CON trial; thereafter all conditions were randomized.  139 
2.5 Data Collection.  140 
During each trial participants wore a noseclip and breathed through a mouthpiece for 141 
breath-by-breath gas-exchange measurements. Inspired and expired volumes and flow rates were 142 
measured using a low dead space (90 mL) bidirectional turbine (Alpha Technologies, VMM 110) 143 
and pneumotach (Hans Rudolph, Model 4813) positioned in series from the mouthpiece (total 144 
apparatus dead space was 150 mL); respired air was continuously sampled at the mouth and 145 
analysed by mass spectrometry (Innovision, AMIS 2000, Lindvedvej, Denmark) for fractional 146 
concentrations of O2 and CO2. The volume turbine was calibrated before each test using a 147 
syringe of known volume (3 L) over a range of flow rates and the pneumotach was adjusted for 148 
zero flow. Gas concentrations were calibrated with precision-analyzed gas mixtures. The time 149 
delay between an instantaneous square-wave change in fractional gas concentration at the 150 
sampling inlet and its detection by the mass spectrometer was measured electronically by 151 
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computer. Respiratory volumes, flow and gas concentrations were recorded in real-time at a 152 
sampling frequency of 100 Hz and transferred to a computer, which aligned gas concentrations 153 
with volume signals as measured by the turbine. Flow from the pneumotach was used to resolve 154 
inspiratory-expiratory phase transitions and the turbine was used for volume measurement. The 155 
computer executed a peak-detection program to determine end-tidal PO2, end-tidal PCO2 and 156 
inspired and expired volumes and durations to build a profile of each breath. Breath-by-breath 157 
alveolar gas exchange was calculated using the algorithms of Swanson (1980).  158 
Local muscle oxygenation of the quadriceps vastus lateralis muscle was measured using a 159 
frequency domain multi-distance near-infrared spectroscopy (NIRS) system (Oxiplex TS, Model 160 
92505, ISS, Champaign, USA) as described elsewhere (Spencer et al., 2012b). Briefly, the 161 
system was comprised of a single channel consisting of eight laser diodes operating at two 162 
wavelengths (Ȝ = 690 and 828 nm, four at each wavelength) which were pulsed in a rapid 163 
succession down a photomultiplier tube. A rigid plastic NIRS probe (connected to laser diodes 164 
and photomultiplier tube by optical fibers) consisted of two parallel rows of light emitter fibers 165 
and one detector fiber bundle; the source-detector separations for this probe were 2.0, 2.5, 3.0, 166 
and 3.5 cm for both wavelengths. The probe was placed on the belly of the muscle, at the distal 167 
end of the vastus lateralis muscle. NIRS measurements were collected continuously for the entire 168 
duration of each trial. The NIRS was calibrated at the beginning of each testing session following 169 
an instrument warm-up period of at least 20 min. Throughout each testing session, continuous 170 
measurements of the absolute scattering (ȝs) and absorption (ȝa) coefficients were determined 171 
from the measured intensity (AC) and phase shift of the light entering and traversing the tissue 172 
(at both wavelengths) such that the absolute concentrations of HHb and O2Hb (in µM) could be 173 
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derived. Data were stored at an output frequency of 25 Hz, but were reduced to 1-s bins for all 174 
subsequent analyses. 175 
Heart rate (HR) was collected using a Polar Wearlink Chest Strap, H1 Heart Rate Sensor 176 
and SP0180 Polar Transmitter (Polar Electro Inc., Lachine, QC, Canada). Arterial O2 saturation 177 
(%O2Sat) was measured using finger pulse oximetry (model 8600, Nonin Medical, Plymouth, 178 
MN, USA). Both HR and %O2sat were continuously monitored using PowerLab Chart v.7.3.1 179 
(ADInstruments Inc., Colorado, CO, USA).   180 
2.6 Data Analysis 181 
Data were analysed in a similar manner to those of Keir et al., (2016b). The on-transient 182 
responses for Vࡆ O2p and [HHb] were modeled with the following mono-exponential function: 183 
Y(t) = YBSL + Ap · (1  e-(t-TD)/Ĳ)   (1) 184 
where, Y(t) is the value of the dependent variable at any time during the transition, YBSL is the 185 
pre-transition baseline value, Ap is the steady-state increase in Y above the baseline value, Ĳ is 186 
the time constant of the response or the time for Y to increase to 63% of the absolute change in 187 
Y, and TD is the time delay. For Vࡆ O2p, phase I was excluded from the fitting window by 188 
progressively moving the window (from ~ 30 s) back towards time zero while examining the 189 
flatness of the residual profile and values of CI95 and Ȥ2 (Rossiter et al., 2001). The end of the 190 
fitting window was set to ~5 times the estimated time constant in order to restrict the modeling to 191 
data lying within the transient phase. Once the optimal fitting window was established a non-192 
linear least squares regression analysis was performed using Origin 8.5 (OriginLab, 193 
Northampton, MA). In order to determine CI95 for ĲVࡆ O2p, model convergence was established 194 
with the Ap and TD parameters first allowed to vary; subsequently, the model was iterated again 195 
with these parameters constrained to best fit values. The mean response time (MRT) of Vࡆ O2p 196 
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described the overall time course of Vࡆ O2p during the exercise transition and was estimated using 197 
the function described in equation 1, with the inclusion of all Vࡆ O2p data but with the TD 198 
constrained to 0 s.  199 
The TD for the [HHb] ([HHb]-TD) response was determined using second-by-second 200 
data and corresponded to the time after the onset of exercise at which the [HHb] signal increased 201 
above 1 SD of the pre-transition baseline value. Determination of the [HHb]-TD was made on 202 
each individuals ensemble-averaged response and the data were modeled using equation 1. 203 
Different fitting strategies ranging from 90-180 s into a transition resulted in minimal differences 204 
in estimates of Ĳ[HHb]. The MRT for [HHb] (MRT-[HHb]) described the overall time for [HHb] 205 
to increase from the start of exercise to 63% of the steady-state value and was calculated as the 206 
sum of Ĳ[HHb] and [HHb]-TD. 207 
2.7 Statistical Analysis  208 
Data are presented as mean ± SD. A two-way analysis of variance (ANOVA) for repeated 209 
measures was used to compare gas exchange and muscle oxygenation variables with the main 210 
effects of condition and time. Comparison of all kinetic parameter estimates were made using a 211 
one-way ANOVA for repeated measures. Where significant effects were found, a Student 212 
Newman-Keuls post hoc analysis was performed for multiple comparisons. All statistical 213 
analyses were performed using SigmaPlot Version 11.0, (Systat Software Inc., San Jose, CA). 214 
Statistical significance was accepted at p < 0.05. 215 
 216 
3. Results 217 
The group mean Vࡆ O2peak  from the ramp-incremental exercise protocol was 3.6 ± 0.5  Lámin-1 218 
(44.2 ± 6.1 mL·kg-1·min-1). This occurred at a POpeak of 336 ± 52 W and corresponded to a peak 219 
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Vࡆ E of 169 ± 33 Lámin-1, peak HR of 196 ± 31 beatsámin-1, and a peak respiratory exchange ratio 220 
of 1.33 ± 0.05.    221 
3.1 Comparison amongst conditions across time 222 
 The mean responses across time for select gas exchange variables are displayed in Figure 223 
1. Table 1 displays the average responses for ventilatory data, PETO2, PETCO2, and O2 saturation 224 
in the last 2 min of baseline and moderate exercise conditions. There were no differences in any 225 
of the gas exchange variables amongst any of the conditions in the pre-accommodation period 226 
(p>0.05). Thereafter, relative to CON, breathing frequency and expired tidal volume were 227 
manipulated in HV, HX, and NC-HX such that Vࡆ E did not differ (p>0.05) amongst the three 228 
experimental conditions (HV, HX, NC-HX) at any time point during the accommodation and 229 
exercise periods of the protocol (Fig. 1A-C). After the pre-accommodation period, PETO2 was 230 
greater in HV (~113 ± 3 mmHg) compared to CON (~97 ± 4 mmHg, p<0.05) and both were 231 
greater than in the HX and NC-HX conditions (~52 ± 3 and ~55 ± 3 mmHg, respectively, Fig. 232 
1D). After pre-accommodation, PETCO2 was reduced in both HV and HX to ~29 ± 2 mmHg, but 233 
was maintained at ~40 ± 1 mmHg in NC-HX such that it was not different from CON in the 234 
accommodation and baseline periods (Fig. 1E). During moderate exercise, PETCO2 was lower 235 
(p<0.05) in NC-HX relative to CON (Fig. 1E and Table 1).  236 
 The NIRS-derived variables were not different for any of the conditions during the pre-237 
accommodation period. The NIRS-derived [Hbtot] was not different amongst conditions at any 238 
time point during the protocol however there was a main effect of time such that [Hbtot] was 239 
greater (p<0.05) in exercise compared to the pre-accommodation, accommodation, and baseline 240 
periods (Fig. 2A). There was a significant condition x time interaction for [O2Hb] such that CON 241 
was greater than all other conditions in moderate exercise (p<0.05) but not during any other time 242 
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periods (Fig. 2B). Similarly, there was a significant condition x time interaction for [HHb] with 243 
the response being greater in NC-HX and HX relative to CON and HV (p<0.05) during exercise 244 
(Fig. 2C) but not at any other times. The muscle tissue O2 saturation index (TOI, %) was not 245 
different amongst conditions (p>0.05) until exercise, thereafter TOI was lower in NC-HX and 246 
HX compared to CON and HV (p<0.05), with TOI being greater in CON than HV (p<0.05, Fig 247 
2D). 248 
 There was a significant condition x time interaction for HR, with HR increasing from 249 
pre-accommodation to accommodation period (p<0.05) and then again from baseline to exercise 250 
(p<0.05) in all conditions. No differences were observed between conditions during pre-251 
accommodation or accommodation periods (p>0.05). During the baseline period, HR was 252 
elevated in HX and NC-HX relative to the CON and HV conditions (p<0.05) and these 253 
differences persisted during exercise. As expected by design, following the pre-accommodation 254 
period, O2 saturation (Fig. 1F) was reduced (p<0.05) in HX and NC-HX relative to CON and 255 
HV. The reduction in O2 saturation in the hypoxic conditions remained constant until exercise, 256 
where it was further reduced (p<0.05).    257 
3.2 Vլ O2p and muscle deoxygenation kinetic responses to moderate-intensity exercise 258 
 Mean parameter estimates for the kinetic responses of Vࡆ O2p are presented in Table 2. 259 
Figure 3 displays the group mean on-transient responses of Vࡆ O2p for each condition with phase 2 260 
exponential model fits derived from the group mean parameter estimates superimposed over the 261 
data. The phase II Vࡆ O2p time constant was different amongst all conditions (CON, 26 ± 11 s; 262 
HV, 36 ± 14 s; HX, 46 ± 14 s; and NC-HX, 52 ± 13 s; p<0.05; Table 2). The mean Lș was 1.90 ± 263 
0.38 Lámin-1 (53 ± 11%Vࡆ O2peak) and the mean exercise power output (102 ± 24 W) corresponded 264 
to ~80% Lș  which elicited a steady-state Vࡆ O2p (Vࡆ O2pSS) ranging from ~1.50 ± 0.2 Lámin-1 (CON 265 
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and HV) to ~1.56 ± 0.2 Lámin-1 (HX and NC-HX) or ~79% and ~82% of the Vࡆ O2p at Lș . The 266 
Vࡆ O2pSS was greater in HX and NC-HX relative to CON (p<0.05). 267 
 Mean parameter estimates for the kinetic responses of [HHb] can be seen in Table 3. 268 
Baseline [HHb] was different between CON and HX only. The [HHb] amplitude was only 269 
greater (p<0.05) in HX compared to CON. The W[HHb] was greater (p<0.05) in HX relative to 270 
CON and there were no differences (p>0.05) amongst conditions for the overall response (MRT-271 
[HHb]) or the [HHb]-TD parameters.   272 
 273 
4. Discussion 274 
Relative to a normoxic control condition, the adjustment of pulmonary (and presumably 275 
muscle) Vࡆ O2 is slowed in response to a step-change in moderate-intensity exercise under 276 
conditions of: i) hypoxic breathing (Bowen et al., 2013; Engelen et al., 1996; Hughson and 277 
Kowalchuk, 1995; MacDonald et al., 2000; Perrey et al., 2005; Spencer et al., 2012a), and ii) 278 
volitional hyperventilation and accompanying hypocapnia and respiratory alkalosis (Chin et al., 279 
2013, 2010a, 2010b, 2007; Hayashi et al., 1999; Ward et al., 1983). A common physiological 280 
feature consequent to both experimental interventions is hyperventilation and hyperventilation-281 
induced hypocapnic alkalosis. We examined whether the slowing of Vࡆ O2p kinetics in hypoxia 282 
was associated simply with reduced O2 delivery, or whether the response was related, in part, to 283 
hyperventilation and its associated hypocapnia. To do so, we examined the effects of hypoxic 284 
breathing or volitional hyperventilation (with induced hypocapnia) alone and the effects of 285 
hypoxic breathing with added CO2 to maintain normocapnia. Recent work in normoxia (Chin et 286 
al., 2013) demonstrated that eucapnic-hyperventilation partially restored the slower Vࡆ O2p 287 
kinetics back towards control values. Therefore, the present study was designed to examine the 288 
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effects of: a) lower arterial O2 availability, b) lower arterial CO2, and c) a combination of both on 289 
Vࡆ O2p and muscle oxy-/deoxygenation response dynamics during the transition to moderate-290 
intensity exercise. 291 
The main findings of this study were that Vࡆ O2p kinetics were slowed with hypoxia (HX) 292 
and with hyperventilation (HV), but the addition of CO2 to the inspirate to maintain normocapnia 293 
during hypoxia did not speed Vࡆ O2p kinetics back towards control values; in fact, it slowed Vࡆ O2p 294 
kinetics even further. In both HX and NC-HX, Vࡆ E was matched such that the work of breathing 295 
between these experimental interventions was assumed not different at any time point during the 296 
protocol. Furthermore, both conditions involved inspiring gas composed of the same fractional 297 
concentration of O2 (12%) that led to a similar PETO2 (and presumably PaO2) in both conditions 298 
(PETO2 ~55 mmHg; O2sat ~80%), but which was less than normal. The only difference between 299 
conditions was that, in HX, PETCO2 was allowed to fall to ~30 mmHg (a value consistent with 300 
the literature for the same level of hypoxia and exercise intensity (Lador et al. 2013; Parolin et al. 301 
2000)) but in NC-HX, the inspired gas was supplemented with CO2 such that PETCO2 remained 302 
near control values (i.e., 40 mmHg). In contrast to our hypothesis, Vࡆ O2p kinetics were slower in 303 
NC-HX (ĲVࡆ O2p ~52 s) compared to HX (ĲVࡆ O2p ~46 s); although this difference should be 304 
interpreted with caution because it is very close to the minimally important difference in ĲVࡆ O2p 305 
for interventional studies (i.e., 5 s) (Benson et al., 2017a). This also is in contrast to the speeding 306 
of Vࡆ O2p kinetics reported by Chin and coworkers (2013) with normocapnic hyperventilation. 307 
The ĲVࡆ O2p in HX increased relative to control by ~75% (ĲVࡆ O2p = 46 s vs. 26 s, for HX 308 
vs. CON, respectively) which is consistent with previous work using a similar level of 309 
normobaric hypoxia (Bowen et al., 2013; Engelen et al., 1996; Hughson and Kowalchuk, 1995). 310 
Furthermore, Vࡆ O2p kinetics were slower in HX (ĲVࡆ O2p = 46 s) compared to HV (ĲVࡆ O2p = 36 s). 311 
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At first glance, this finding supports an additive contribution of lower arterial CO2 and lower 312 
arterial O2 to slower Vࡆ O2p kinetics: that is, relative to CON (ĲVࡆ O2p = 26 s), hypoxia increased 313 
ĲVࡆ O2p by 10 s and hypocapnia by an additional 10 s (26 + 10 + 10 = 46 s). However, were this to 314 
be a truly additive interaction, elimination of one or both of these factors should reduce or 315 
completely restore Vࡆ O2p kinetics, respectively, towards control values. Although eliminating low 316 
arterial O2 (i.e., HV) restored Vࡆ O2p kinetics towards control values (ĲVࡆ O2p decreased from 46 to 317 
36 s), the same effect was not observed with the removal of lower arterial CO2 (i.e., NC-HX; 318 
ĲVࡆ O2p increased from 46 to 52 s). Given that Vࡆ E was matched in all of these conditions, our 319 
findings indicate that the addition of low arterial CO2 in conditions of low arterial O2 may 320 
paradoxically prevent a further slowing Vࡆ O2p kinetics in acute hypoxia. 321 
The postulated mechanisms responsible for the slowed adjustment of pulmonary (and 322 
muscle) Vࡆ O2 in acute hypoxia are a reduction in both convective and diffusive O2 delivery to 323 
muscle  (Bowen et al., 2013; DeLorey et al., 2004; Lador et al., 2013; Perrey et al., 2005; Roach 324 
et al., 1999), and slow activation of PDH (Parolin et al., 2000; and possibly other rate-limiting 325 
enzymes). We reasoned that any of these limiting factors could be rectified by preventing 326 
hypocapnia during hypoxic exercise. In theory, preventing hypocapnia with CO2-breathing 327 
should facilitate greater peripheral O2 delivery by preventing a hypocapnic-induced leftward-328 
shift in the oxyhemoglobin dissociation curve (the Bohr effect). In this instance, for the same 329 
Vࡆ O2p and O2 extraction requirement, microvascular PO2 should remain higher and facilitate 330 
diffusive transport into muscle. The slower Vࡆ O2p kinetics in NC-HX relative to HX were 331 
accompanied by no differences in the rate (Ĳ; MRT) or magnitude of change (amplitude) in 332 
[HHb] during the on-transient. This suggests that microvascular O2 delivery increased at a slower 333 
rate in NC-HX. Therefore, it is possible that any enhancement in microvascular PO2 and thus 334 
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diffusive O2 delivery consequent to preventing hypocapnia with CO2-supplementation in the 335 
hypoxic condition was offset by a reduction in convective O2 delivery. For example, in hypoxia, 336 
a decrease HbO2 affinity is expected with the higher CO2 (and H+), that accompanies CO2 337 
supplementation, which could contribute to a lower HbO2 and thus convective O2 delivery. At 338 
the same time, the presence of more CO2 (and H+) in hypoxia could increase competition for 339 
binding sites on Hb via the Haldane effect, resulting in a greater formation of carbamino 340 
compounds (Roughton, 1935). However, in our study the NIRS-derived HbO2 was not different 341 
in HX and NC-HX. Alternatively, maintaining eucapnia during hypoxia with CO2-342 
supplementation may augment the systemic vasodilatory effect of low PO2 directly by CO2-343 
mediated vasodilation (Clifford and Hellsten 2004). Lower systemic vascular resistance of non-344 
active tissue in NC-HX (relative to HX) could impair the distribution of cardiac output, and thus 345 
convective O2 delivery to active muscle during the transition to moderate exercise.  346 
Alternatively, maintenance of eucapnia during hypoxic exercise should improve 347 
activation of rate limiting enzymes (e.g., PDH) via a prevention of a cellular respiratory alkalosis 348 
(Parolin et al., 2000). Thus, although PDH activity is depressed during hypoxia, preventing 349 
intracellular alkalosis by CO2 breathing may alleviate the alkalosis-induced inhibition of PDH 350 
(LeBlanc et al., 2002) resulting in faster Vࡆ O2p kinetics in NC-HX relative to HX. For instance, 351 
Parolin et al. (2000) observed that submaximal exercise performed with hypoxic breathing was 352 
associated with an attenuated activation of PDH (a rate-limiting step in the delivery of 353 
carbohydrate derived substrate to the mitochondria). Similarly, mismatch between cytosolic 354 
pyruvate production and mitochondrial pyruvate oxidation (evidence of attenuated PDH 355 
activation) was also observed consequent to volitional hyperventilation-induced hypocapnic 356 
alkalosis during an identical exercise protocol (LeBlanc et al. 2002). However, in the present 357 
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study maintenance of normocapnia during hypoxic breathing did not speed Vࡆ O2p kinetics in NC-358 
HX relative to HX suggesting that a hypocapnia-induced inhibition of PDH was not the cause of 359 
slower Vࡆ O2p kinetics in the hypoxic conditions. Therefore, the mechanism by which Vࡆ O2p 360 
kinetics are slowed in hypoxia appears not to be a result of reduced PaCO2. On the contrary, low 361 
PaCO2 in hypoxia appears to be mildly protective of slowing Vࡆ O2p kinetics, which may be a 362 
consequence of microvascular O2 delivery being less well matched to demand during eucapnic 363 
hypoxia compared with hypocapnic hypoxia.  364 
The alveolar air equation predicts that for the same FiO2 (0.12) and respiratory exchange 365 
ratio, a 10 mmHg increase in PaCO2 would result in a 12 mmHg decrease in alveolar PO2. 366 
Therefore, it is possible that hypoxia may have been more severe in NC-HX relative to HX. 367 
Although this could explain slower Vࡆ O2p kinetics in NC-HX relative to HX, both O2 saturation, 368 
and PETO2 were not different between conditions suggesting that arterial PO2 was not different 369 
and the NIRS-derived muscle microvascular data also were not different between NC-HX and 370 
HX refuting differences in the level of hypoxia at the muscle. 371 
4.1 Limitations 372 
 Although phase II Vࡆ O2p kinetics are reflective of the muscle Vࡆ O2 kinetics, they are 373 
expressed at the lung in conjunction with phase I. Phase I is largely determined by pulmonary 374 
blood flow kinetics and the O2 concentration of mixed venous blood arriving at the lung (Benson 375 
et al., 2013). Even though we matched Vࡆ E between experimental conditions, such that the work 376 
of breathing should be similar, it is possible that differences in the partial pressure of inspired 377 
(and presumably arterial) O2 and CO2 between conditions could have influenced the early 378 
dynamics of blood flow and therefore phase I Vࡆ O2p kinetics (i.e., amplitude and time constant). 379 
Indeed there are clear differences between phase I Vࡆ O2p amplitude among CON and 380 
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experimental conditions (phase I is greater in HX and NC-HX than COND and HV; Figure 3). 381 
Dynamic circulatory differences (if present) influence phase I and phase II Vࡆ O2p kinetics 382 
directly, and could contribute to condition-specific dissociations between muscle and pulmonary 383 
Vࡆ O2  (Benson et al., 2017b, 2013). In addition, control of ventilation and inspired O2 and CO2 384 
were used to manipulate the PO2 and PCO2 at the arterial and muscle level. However, the 385 
different combinations of low and high PETO2 and PETCO2 that were used could have led to 386 
unintended condition-specific physiological adjustments (e.g., via acid-base changes in various 387 
tissue compartments or activation of the sympathetic nervous system, differences in respiratory 388 
muscle work) that could conflate to influence the Vࡆ O2p kinetics of each condition. 389 
5. Conclusion  390 
Exercise in hypoxia incurs conditions of both lower arterial PO2 and lower arterial PCO2. 391 
Because the addition of inspired CO2 during hypoxic exercise did not speed Vࡆ O2p kinetics, our 392 
findings suggesting that the hypoxia-induced hyperventilation with associated hypocapnia does 393 
not contribute to the slowing of Vࡆ O2p kinetics in the hypoxic condition. In fact, hypocapnia 394 
actually may prevent a further slowing of Vࡆ O2p kinetics when arterial O2 availability is lowered. 395 
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Figure Captions 513 
Figure 1. Time course of group mean ventilation (Vࡆ E), breathing frequency (fbr), expired tidal 514 
volume (VT), end-tidal pressure of O2 (PETO2), end-tidal pressure of CO2 (PETCO2), and O2 515 
saturation (O2sat) for CON (white circles), HV (light grey squares), HX (dark grey triangles) 516 
and NC-HX (black circles) conditions. Vertical dashed lines separate the pre-accommodation 517 
(seated rest), accommodation (seated rest), baseline (20 W cycling), and moderate exercise 518 
(cycling at 85% estimated lactate threshold) periods.  519 
Figure 2. Ensemble-averaged group mean response of NIRS-derived variables: total hemoglobin 520 
([Hbtot]), oxygenated hemoglobin ([O2Hb]), deoxygenated hemoglobin ([HHb]), and tissue 521 
oxygen index (TOI) for CON (white circles), HV (light grey circles), HX (dark grey circles) and 522 
NC-HX (black circles) conditions. Vertical dashed lines separate the pre-accommodation (seated 523 
rest), accommodation (seated rest), baseline (20 W cycling), and moderate exercise (cycling at 524 
85% estimated lactate threshold) periods. 525 
Figure 3. Ensemble-averaged group mean responses for Vࡆ O2p in all four conditions. Vertical 526 
dashed lines indicate the onset of moderate exercise (time = 0 s) transition. The group mean 527 
phase II kinetic responses for each condition are superimposed over the data (dark lines, fitted 528 
with a mono-exponential function using group mean parameter estimates) and the group mean 529 
phase II fit of the control condition (dashed black line) is displayed on the hyperventilation, 530 
hypoxia, and normocapnic hypoxia panels. Group mean (± SD) ĲVࡆ O2p values are inset under 531 
each transition and residuals are shown about y = 0 (grey line).   532 
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Table 1. Comparison of parameters for each test condition. 533 
Condition 
 
Control 
 
Hyperventilation 
 
Hypoxia 
 
Normocapnic 
Hypoxia 
Ventilatory requirement Normal hyperventilation hyperventilation hyperventilation 
Percentage of inspired O2 (%) 20.9 20.9 12.0 12.0 
Percentage of inspired CO2 (%) 0.03 0.03 0.03 5.0 
 Baseline 
Frequency (breathsámin-1) 14 ± 5b,c,d 24 ± 5a 24 ± 1a 24 ± 5a 
Tidal Volume (L) 1.7 ± 0.4 1.7 ± 0.4 1.6 ± 0.4 1.7 ± 0.4 
Ventilation (Lámin-1) 22 ± 4b,c,d 39 ± 5a 37 ± 6a 40 ± 5a 
End-tidal PO2 (mmHg) 98 ± 3b,c,d 115 ± 2a,c,d 52 ± 4a,b 55 ± 3a,b 
End-tidal PCO2 (mmHg) 40 ± 3b,c 28 ± 2a,d 28 ± 2a,d 40 ± 1b,c 
O2 saturation (%) 97 ± 1c,d 98 ± 0c,d 85 ± 5a,b 85 ± 2a,b 
 End-exercise 
Frequency (breathsámin-1) 18 ± 5b,c,d 26 ± 2a 25 ± 1a 26 ± 2a 
Tidal Volume (L) 2.3 ± 0.6 2.5 ± 0.3 2.4 ± 0.3 2.6 ± 0.3 
Ventilation (Lámin-1) 40 ± 4b,c,d 66 ± 7a 64 ± 9a 69 ± 10a 
End-tidal PO2 (mmHg) 95 ± 6b,c,d 113 ± 3a,c,d 51 ± 2a,b 53 ± 3a,b 
End-tidal PCO2 (mmHg) 45 ± 4b,c,d 29 ± 2a,d 30 ± 2a,d 41 ± 1a,b,c 
O2 saturation (%)  97 ± 1c,d 99 ± 1c,d 79 ± 5a,b 80 ± 4a,b 
  534 
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Table 2. Kinetics parameters for pulmonary O2 uptake responses at rest and during moderate-intensity exercise in each condition: 535 
Control, Hyperventilation, Hypoxia, and Normocapnic hypoxia. 536 
 537 
Condition Control Hyperventilation Hypoxia Normocapnic Hypoxia 
Vࡆ O2p acc (L·min-1) 0.37 ± 0.04 0.39 ± 0.04 0.40 ± 0.03 0.38 ± 0.05 
Vࡆ O2p bsl (L·min-1) 0.76 ± 0.07 0.77 ± 0.07 0.81 ± 0.05 0.77 ± 0.04 
Vࡆ O2pss (L·min-1) 1.50 ± 0.21 1.52 ± 0.21 1.56 ± 0.19a 1.56 ± 0.23a 
Ap (L·min-1) 0.73 ± 0.23d 0.75 ± 0.22 0.75 ± 0.22 0.79 ± 0.24a 
TD (s) 9 ± 7 2 ± 9 -7 ± 10 -13 ± 10 
ĲVࡆ O2p (s) 26 ± 11b,c,d 36 ± 14a,c,d 46 ± 14a,b,d 52 ± 13a,b,c 
CI95 (s) 3 ± 1 3 ± 1 3 ± 1 3 ± 1 
¨Vࡆ O2p /¨PO (mL·min-1·W-1) 8.9 ± 0.4 9.1 ± 0.4 9.4 ± 1.0 9.6 ± 0.6a 
 538 
Values are means ± SD. Vࡆ O2p, pulmonary O2 uptake; Vࡆ O2p acc, resting Vࡆ O2p; Vࡆ O2p bsl, baseline Vࡆ O2p; Vࡆ O2p ss, steady-state Vࡆ O2p; Ap, 539 
amplitude of Vࡆ O2p response; TD, time delay; Ĳ Vࡆ O2p, time constant for Vࡆ O2p response; CI95, 95% confidence interval for ĲVࡆ O2p; 540 
¨Vࡆ O2p /¨PO, functional gain. a significant (p < 0.05) difference from control. b significant (p < 0.05) difference from hyperventilation. 541 
c significant (p < 0.05) difference from hypoxia. d significant (p < 0.05) difference from normocapnic hypoxia.542 
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Table 3. Kinetic parameters for vastus lateralis muscle deoxygenation ([HHb]) from Control, Hyperventilation, Hypoxia, and 543 
Normocapnic hypoxia. 544 
 545 
Condition Control Hyperventilation Hypoxia Normocapnic Hypoxia 
[HHb]bsl (ȝM) 33 ± 9 31 ± 8d 33 ± 9 35 ± 9b 
[HHb]amp (ȝM) 7 ± 5c 9 ± 6 10 ± 7a 9 ± 7 
[HHb]-TD (s) 12 ± 3 12 ± 4 10 ± 2 11 ± 3 
Ĳ[HHb] (s) 8 ± 3c 9 ± 3 13 ± 4a 10 ± 3 
MRT-[HHb] (s) 20 ± 3 21 ± 5 23 ± 5 21 ± 4 
CI95 (s) 2 ± 1 1 ± 1 2 ± 0 2 ± 1 
 546 
Values are means ± SD. [HHb], deoxyhemoglobin concentration; [HHb]bsl, baseline [HHb]; [HHb]amp, amplitude of [HHb], [HHb]-547 
TD, time delay; Ĳ[HHb], time constant for [HHb] response; MRT-[HHb], mean response time (Ĳ[HHb] + [HHb]-TD); C95, 95% 548 
confidence interval for Ĳ[HHb]. a significant (p < 0.05) difference from control. b significant (p < 0.05) difference from 549 
hyperventilation. c significant (p < 0.05) difference from hypoxia. d significant (p < 0.05) difference from normocapnic hypoxia. 550 
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